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Smooth muscle cells (SMCs) play an important role in the contraction of gastrointestinal 
(GI) smooth muscles, generating spontaneous action potentials and forming electrical and 
mechanical junctions coupling with interstitial cells. Recent studies have shown that 
microRNAs (miRNAs), a new class of small RNAs that function as guide molecules in 
RNA silencing, regulate and maintain the differentiation state of SMCs. A transgenic 
animal model to study SMC-specific knockout of Dicer, one of two RNase III proteins in 
miRNA biogenesis, showed that contractile motility in the mutant intestine was 
dramatically decreased (Park, Yan, et al., 2011). The purpose of this study was to 
investigate the function of Drosha, another of the two RNase III proteins in miRNA 
biogenesis, in intestinal SMCs using a transgenic animal model. We generated SMC-
specific inducible Drosha null animals (smMHCCre-ERT2/+;Droshalox/lox) by cross-breeding 
a smMHC/Cre/eGFP (smMHCCre-GFP/+) male mouse and a Droshalox/lox female 
homozygote mouse. The inducible SMC-specific knockout (KO) mice caused severe 
changes in phenotype and function of the GI tract. Morphological study of the GI smooth 
muscle showed that the KO mice developed a thicker muscle layer of the intestinal tract 
from the upper duodenum to the jejunum down to the whole colon. Histological serial 
sections stained with hematoxylin and eosin (H&E) showed hypertrophy in both jejunum 
and colon SM layers. This phenotype can be at least partially explained by the loss of 
SMC-specific miRNAs, miR-143 and miR-145, identified as regulators of SMC growth 
and/or differentiation. In conclusion, the data gathered in the present research suggests 




research is needed to understand the complete molecular mechanisms required for 
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MicroRNAs (miRNAs) are small non-coding RNAs that are important regulators 
of cellular and molecular processes and are highly conserved across many species, such 
as rodents, birds, fish, primates, and viruses (Ro et. al., 2007). In a study by Ro and his 
colleagues, miRNAs function as post-transcriptional suppressors, and they work by 
binding to target mRNAs through base pairing and then destabilize the mRNA or depress 
translational processes. miRNAs are extremely important in the regulation of 
transcriptional factors and they also control apoptotic and proliferative gene expression in 
smooth muscle. There have also been many studies that link miRNAs directly to 
tumorigenesis, viral diseases, and various developmental diseases (Ro et. al., 2007).  
  Drosha is a nuclear RNase that completes the initial state of miRNA processing 
inside of the nucleus of the cell. It is mainly involved in pre-rRNA processing in the 
nucleus and cleaves primary miRNAs into precursor miRNAs during miRNA biogenesis 
(Lee, et al., 2003). These miRNAs regulate genes after transcription and play critical 
roles in development of mammals. Studies have shown that miRNAs are crucial in the 
proliferation and the differentiation of cells during development (Albinsson et. al., 2010). 
miRNAs are also able to regulate proliferation and differentiation of SMCs, and some 
miRNAs, such as mir-143/145, have been discovered to regulate cell development in 
many human disorders (Boettger et. al., 2009 and Elia et. al., 2009).  
In this study, we focused on looking at smooth muscle cells (SMCs) that support 
motor activities in the gastrointestinal (GI) tract, which can display different phenotypes 
based on acquired or congenital diseases, especially the hypertrophy as a result of severe 




caused by extreme changes in gene expression driven serum response factor (SRF), 
which is a master switch for the expression of contractile and cytoskeletal genes (Park, 
Hennig, et. al., 2011). Cells were identified for changes by myosin heavy chain 11 
(MYH11) which is a marker for differentiated smooth muscle, Ki-67, which is a marker 
in turn for cell proliferation and upregulation in hypertrophic tissues in the GI (Scholzen 
& Gerdes, 2000), PDGRF α and β, and DAPI, which is a marker for cellular nuclei (Otto, 
2008). 
 In this study, we are focusing on how the loss of miRNAs affects the phenotype in 
GI SMCs in the SMC-specific Drosha mouse model.  The Drosha mice show features of 
chronic intestinal pseudo-obstruction (CIPO), more likely known as megacystic-
microcolon intestinal hypoperistalsis syndrome (MMIHS), which causes serious 
functional, morphological, and genetic defects (Rolle et. al., 2002) that originate in the GI 
SMCs. This mouse model will help to understand the regulation of the phenotype by 
irregular gene expression in SMCs due to the knocking out of miRNAs. This study will 
provide new insight on the interaction between miRNAs and the role they play in target 
genes in SMCs during mouse development, and will in turn provide new understanding in 




Study site: Ro laboratory, Anderson Health Sciences Building 107 and 109 at the 
University of Nevada, Reno School of Medicine 
 
Studies were performed on laboratory mice (Mus musculus). All mice were 




with an open source of mouse chow. Starting this project, there were 71 total Drosha 
mice, which consisted of 39 males and 32 females. These mice were generated form 
previous experiments. 55 mice were sacrificed because they did not have the correct 
genotypes for experimentation. With the remaining 16 mice, we paired smMHCCre-ERT2/+ 
(male) X Droshalox/lox (female) and smMHCCre-ERT2/+;Droshalox/+ (male) X Droshalox/lox 
(female). After breeding these mice, we then had a final breeding pair, which was 
smMHCCre-ERT2/+;Droshalox/lox (male) X Droshalox/lox (female) in order to generate 
experimental mice.  The correct genotype for experimental male mice is smMHCCre-
ERT2/+;Droshalox/lox. After breeding and obtaining the correct genotype we injected 
tamoxifen in experimental mice and sunflower oil and water for control mice for 5 
consecutive days for 3-week old mice and once a week thereafter.  
We monitored the mice and weighed them twice per week at the same time. We 
used both a knockout experimental mouse (KO) and a wild type control mouse (WT). 
The KO and WT control genotypes for congenital mice were smMHCCre-
ERT2/+;Droshalox/lox and for inducible mice were smMHCCre/+;Droshalox/lox. Experimental 
mice were killed at 4, 8, and 12 weeks post tamoxifen injection, respectively. After 
dissecting the knockout and control mice, we took gross images in order to compare the 
deterioration of the knockout mouse gastrointestinal tract to that of the control mouse. 
We then extracted the whole GI from each mouse and then peeled the smooth muscle 
layer of the jejunum from the mucosa layer and also did cross sections of the tissue of 
interest. The smooth muscle layer was then taken to do H&E staining and 




When the mice died 11-12 weeks post-injection, we first took gross images, then 
proceeded with H&E staining with cross sections and with immunohistochemistry (IHC) 
and marked the SMCs with Myosin heavychain 11 (MHY11), Ki-67, Serum Response 
Factor (SRF), and PDGRF α and β.  
Projected outline of the experimental plan: 
1. Breed mice (genotyping) 
1) smMHCCre-ERT2/+ (male) X Droshalox/lox (female) 
 
2) smMHCCre-ERT2/+;Droshalox/+ (male) X Droshalox/lox (female) 
 
3) Breeding paris (2 cages) 
smMHCCre-ERT2/+;Droshalox/lox (male) X Droshalox/lox (female) 
 
Experimental mice 
smMHCCre-ERT2/+;Droshalox/lox (male)  50% 
 
Inject tamoxifen in 5 consecutive days at 3 wks old 
KO and WT control (smMHCCre-ERT2/+;Droshalox/lox, smMHCCre-ERT2/+;Droshalox/+, or 
mMHCCre-ERT2/+) 
Monitor the mice (weight every week) 
When the mice die (8-12 wks) 
At 4, 8, 12 weeks the following are to be done: 
Images:  
1) Gross image 
2) H&E staining with cross sections 
3) IHC with MHY11, Ki-67, Serum Response Factor (SRF), and PDGRF α and β.  
4) miR-143/145: primary, precursor, mature miRNA expression in jejunum smooth 
muscle (KO and WT) 
 
 
Ear Punch and Genotyping procedure: 
 
Ear punches are required in order to identify the mice in each cage. The pups are 
identified based on sex and ear punches on either the right or left ears. Mice pups from 
age 7-10 days old are removed from their respective cages and restrained by scruffing 
them on the neck. Then taking the ear punch and placing the flat side behind ear, the tool 




Primers for Drosha line: 
 
1. Myh-11/Er2+Cre-2 -> 232 = +, 326 + 232 = Cre 
2. Dorosha F+R -> 251 = WT, 301 = lox  
3. Dorosha-Del-F/Del-R, del = 519 
	  
70% Ethanol. This process was repeated until all mouse pups in the cage received 
identification notches and were recorded.  
 
In order to genotype the mice, Ethyl Chloride, a freezing agent, was sprayed on the end 
of the tail of each mouse. After the end of the tail turned white, indicating that the tail is 
ready to be snipped and that the mouse will feel no cutting, sharp scissors were used to 
cut 1-2 mm off the end of the tail. The tail sample was then placed in a labeled container 
indicating which mouse the sample came from. Making sure that the end of the tail was 
completely dry from the Ethyl Chloride, the end of the tail was quickly cauterized using 
the cautery tool. The pup was then placed back in its cage with its mother. This process 
was repeated until all the mice in a cage were genotyped.   
 
 
To extract genomic DNA from mouse tail sample to determine genotype: 
 
First, 100µl of extraction buffer was placed inside of a 2 ml tube with each tail sample. 
Then the tubes were incubated at 95C for 30 minutes. The tail sample was able to cool to 
room temperature and then immersed in 100 ml of stabilization buffer. The sample was 
ready to use immediately but could be stored at -20C until ready to use. 
 
Polymerase Chain Reaction (PCR) and gel electrophoresis: 
 
A mastermix was made in an Eppendorf tube, which includes the following: 
a. 1 µl forward primer 
b. 1 µl reverse primer 
c. 8.5 µl molecular base water 










Then 10.5 µl of mastermix was pipetted into each 30 µl PCR tube (n tubes). 2 µl of the 
mouse tail DNA sample was added, as well as 12.5 µl of PCR supermix, to each tube and 
then pipetted up and down to mix. Flicking and centrifuging each PCR tube removed 
bubbles. The PCR was put into the thermocycler (individual cycling parameters for 
different primers). After PCR cycle is done, 1.5µl of each sample was pipetted into an 
individual well, along with a 100 base pair DNA ladder, into a 2% agarose gel submerged 
in 1X TAE buffer. The gel was positioned in the gel box so that the black electrode was 
nearest to the sample wells and the red electrode was farthest away. This insures that the 
DNA travels down the gel and that the bands can be clearly seen. The gel is then run on 




The power supply was turned off, and the gel was removed from the voltage apparatus. 
Wearing gloves, I gently tipped the gel on its side to remove any excess TAE buffer. The 
gel was then placed in the lower shelf of the Bio-Rad imager and placed inside and 
moved back and forth to ensure no bubbles were underneath the gel. The black power 
box was switched on and Quantity One program was opened. After selecting a new file, 
Chemdot XRS, and the Epi white button on the imager itself, the Live focus button was 
selected and the gel was adjusted by hand using the ruler. The imager was shut tight and 
the “Trans UV” button was pressed. In order to take the picture, the “freeze” button was 




inverted by clicking “image” then “transform” and finally “inverted display”. The image 
was then cropped and saved in the file directory. 
 
Tamoxifen injections: 
Tamoxifen injections result in the activation of expression of the Cre gene only in smooth 
muscle cells. Tamoxifen solution are made by mixing 40 mg of Tmx with 400 µl of 
100% Ethanol in a 2 ml tube. The mixture was vortexed for 20 minutes until no 
tamoxifen particles were visible to insure the Tmx was completely dissolved. After 
vortexing, 3.6 ml of sunflower oil via a 0.8 µl syringe filtration was added. The solution 
was aliquotted into 0.5 ml tubes and was then placed in aluminum foil to shield from 
light. The samples were transferred to the sonicate machine and sonicated for 20 minutes. 
After sonication, the samples were stored in the 4C fridge until ready for injection.  
 
At 21 days old, knockout mice were injected with 2 cc (200 ul) containing 2mg of 
tamoxifen and control mice were injected with 2 cc sunflower oil and Ethanol. Each 
sample was placed in a syringe and shielded from light. To stabilize the mouse for 
injection, each mouse was scruffed by the neck and the tail pinned between the ring and 
pinky fingers. After stabilization, alcohol was rubbed on the left side of the abdomen 
above the kidney where injection would take place. Tipping the mouse upside down (so 
as not to puncture the guts) the Tamoxifen was injected slowly so the solution could 
dissipate in the body of the mouse. After injection, the injection site was massaged gently 
and the mouse was returned to its cage. This was done for 5 consecutive days. Mice were 





Extraction of gut smooth muscle tissue from mouse: 
 
Sacrificing the mouse: 
First, Krebs buffer solution was poured in a 200 ml falcon tube and stored on ice. To 
sacrifice a mouse, the subject was taken into Anderson Room 110 under a hood. 4 drops 
of Flouriso were placed into a container, along with the mouse, then covered until the 
mouse stopped respiring and died. Taking the mouse out of the container, and over to a 
bench top, tweezers were placed against the back of the mouse’s neck. Cervical 
dislocation was done by pulling back hard on its tail, until popping and clicking noises 
occurred, indicating that the neck had been dislocated and therefore insuring that the 
mouse was dead.  
 
Dissection of mouse: 
 
Placing the mouse on its back, pins were placed in its arms and legs in order to stabilize 
the subject for dissection. Using tweezers, the skin on the stomach was pulled up and 
snipped with scissors. After the skin was cut, the membrane sac was exposed and then 
pulled up and snipped to open the abdominal cavity of the mouse. The skin around the 
whole abdomen was cut away so that the guts were exposed. Using tweezers and small 
scissors, the esophagus and blood vessels behind the stomach were located and then cut. 
These were then pulled out of the body to make locating the colon easier. The colon was 
then found and snipped at the location next to the anus. The whole gut was then separated 
from the body. The whole gut was immediately transferred to a 50                                                      
ml falcon tube containing Krebs buffer and the mouse carcass was then placed in the 




Mesenteric	  Border	   Gut	  
Pin	  
Krebs buffer and put under a microscope. The blood vessels and fat were then cut away 
in order to straighten out the intestines as shown below. 
 
A small portion, about 1 cm in length, of the appropriate section of the intestines was cut 
and pinned down at the mesenteric border while rest of the intestines were removed from 
the petri dish. The pinned section of the gut was then cut open so that the mucosa layer 
was facing up.  
 
 












Fixing dissected GI tissue (whole mount and cross sections): 
 
Whole mount: 
A plastic pipette was used with Krebs buffer to gently wash away the contents that were 
inside of the gut. The soiled Krebs in the petri dish was then replaced with fresh Krebs 
buffer. Then, four pins were placed in each corner of the tissue sample. Using two pairs 
of forceps, the corner of the mesenteric border was gripped and the mucosa layer was 
gently pulled to separate it from the transparent smooth muscle layer underneath it. After 
the smooth muscle layer had been isolated, it was moved to a smaller plate, stretched, and 




refrigerator for approximately 1 hour and 20 minutes to fix the tissue. After letting the 
tissue fix, the PFA was washed away by transferring to test tubes and filling the tubes 
with 1X TBS. These tubes were placed in a rotator and left overnight to rinse.  
 
The next day, the tissues were moved with forceps to a 24 well plate, and each well was 
clearly labeled. The wells were then filled with blocking solution (4% dry-milk/0.5% 
Triton-X/TBS) and incubated at room temperature for 1 hour on a rocker. Then primary 
antibody was diluted in a container of blocking solution in a ratio of 1:200. The blocking 
solution in the wells was then removed and replaced with 500µl of the diluted antibodies. 
The wells were covered with Parafilm and incubated on a rocker at 4C for 48 hours.   
 
After incubation, the wells were washed by rocking 5-10 times with 0.5 ml of 1X TBS at 
room temperature. Secondary antibody composed of Alexa Fluor 594 Goat anti-rabbit 
IgG was diluted in a 1:1000 ratio in blocking solution. 500µl was pipetted into each well 
and incubated for 1 hour at room temperature in the dark.  After incubation, the tissues 
were washed 8 times for 5 minutes with 0.5 ml of 1X TBS at room temperature in the 
dark. Each well was taken to a dissection microscope and carefully mounted onto a clean 
glass slide with forceps with the circular muscle facing up. The tissues were allowed to 
dry on the slides for 3 hours at room temperature in the dark. After drying, 15µl of 
Prolong Gold with DAPI was applied to each slide and a coverslip was placed on each of 
them. The slides were then incubated for 24 hours at room temperature in a dark room. 






To begin fixing the tissues, 4% PFA was thawed in warm water and filtered by using a 30 
ml syringe to pull up the PFA and a micro filter to filter the solution. Some fat was 
trimmed off of the gut section. Fat made the tissue easier to pin during the fixing period, 
but excess fat would complicate freezing tissue in the right orientation. A syringe and 
forceps were used to squirt Krebs buffer through the dissected sections of the GI to clean 
any debris left over. A glass tube was then gently inserted through the lumen and 
transferred to a small dish with gel for pinning. Pins were placed on the sides of the tissue 
where the exposed ends of the glass tube were to hold the sample in place. The sample 
was immersed in 4% PFA and left in the 4C for 1 hour and 20 minutes.  After this 
incubation, PFA was washed from the tissue by transferring the sample to a test tube and 
filled with 1X TBS and placed in a balanced rotator 5 minutes. This was repeated 3 times 
to properly wash the tissues. The sample was then placed in a test tube containing 20% 
sucrose and left in the 4C refrigerator overnight. 
 
The next day, freezing of the tissue sample took place. First liquid nitrogen was collected 
from a container in Anderson 107B. Then, OCT:20% sucrose in PBS solution was made 
by pouring the OCT into the tube containing 20% sucrose in PFA in a 2:1 ratio (e.g. 30 
ml OCT + 15 ml sucrose). The solution was left alone until the bubbles in the mixture 
disappeared and then mixed gently with a transfer pipette. A freezing station was set up 
by using a polystyrene boat and a medium weigh boat. The weigh boat was placed inside 
of the boat and then filled with 95% ethanol. Liquid nitrogen was then added to the 





Samples to be frozen were prepared by cutting 2-3 mm of fully intact sections. The ends 
of the sample were not to be used because of general wear and tear of pinning the tissues. 
OCT:20% sucrose was poured into the cryo molds. The cut samples were placed in the 
mold with the lumen of the samples perpendicular to the bottom of the mold. Once the 
ethanol in the weigh boat becomes slushy, the mold was placed into the ethanol and 
balanced until it froze. Mold contents froze slowly from the outside towards the center, 
and once entirely frozen, ethanol was wiped away with a kim wipe from the sides of the 
mold, carefully avoiding the frozen OCT sucrose solution. Each mold was labeled and 
stored in the -20C until each mold was completed and then transferred and left overnight 
in the -80C freezer.  
 
The next day, the frozen molds were sliced via the cryostat machine in Anderson 111. To 
operate the cryostat, the key button and light key were pressed to turn the machine on. A 
dollop of OCT was placed on the metal cryo mold guide. The frozen sample was placed 
on top of the OCT and set into place by using the stamp inside of the machine. The 
plastic outside of the mold was gently peeled off once the frozen sample was stable. 
While sample was given time to stick to the metal guide, slides were labeled with the date 
and tissue sample information. The frozen sample was then situated into the machine for 
slicing. The sample was trimmed to get the surface of the sample even. Then, the desired 
thickness of the slice was chosen (5 µm ideal). A test slice was done and then 
disregarded. Then, the sample was slowly sliced and with a soft brush, and the thin layer 




sample, the front edge was gently pulled as to not have the slice fold back on itself. A 
slide with the logo facing down was dropped directly onto the slice. This process was 
repeated until 2 sections of the same sample were placed on each slide. The quality of the 
slides was checked under a light microscope. The slides with the newly placed samples 
were left out to air dry for at least 1 hour or overnight before performing washes for 
immunohistochemistry (IHC) or H&E staining.  
 
Hematoxylin and Eosin (H&E) Staining 
The slides underwent H&E staining. This procedure makes the cells, which are initially 
colorless, stained in a way to make them visible under a microscope. H&E refers to 
hematoxylin and eosin, which are the two dyes used to stain the cell tissue, specifically 
DNA and proteins. Hematoxylin is a basic dye that stains acidic structures like DNA a 
purplish blue. Eosin is an acidic dye that is used to stain basic structures like proteins and 
stains them a light pink color (Fischer et. al., 2014). Once the slides were prepared, the 
sections were stained with hematoxylin for 2 minutes by pipetting them directly onto the 
tissues. Then the slides were rinsed twice for 1 minute with tap water and once again for 
2 minutes using distilled water. The Sections were then stained with eosin for 30 seconds 
by pipetting the dye directly onto the slides. They were then rinsed 1 time for 1 minute 
with distilled water. The slides were washed once for 5 minutes by submerging it in 80% 
EtOH, then twice for 5 minutes with 95% EtOh, and then twice again for 5 minutes using 
100% EtOH. After this washing, the slides were then washed twice for 5 minutes using 






IHC was performed the next day after the slides were able to dry. IHC refers to the 
process where proteins are detected in the cells of a tissue being examined by using 
antibodies that bind to the specific proteins in tissues. IHC makes it possible to visualize 
the localization and distribution of particular antigens (like proteins) within cells (Prabin 
et. al., 2009). The slides were then rinsed twice for 5 minutes in 1X TBS by full 
immersion. The tissue on the slide was circled with a wax pen (the circle being 2-3x 
bigger than the tissue). To block the slides, TBS with 0.01% tween and 4% dry milk was 
added for 15 minutes. The slides were then washed twice in 1X TBS by full immersion. 
The primary antibody was then diluted in a 1:200 ratio (e.g. 5µl aliquot of SM myosin 
rabbit IgG in a tube with 995µl of blocking reagent).  The primary antibody was applied 
directly onto the slides with a pipette and then covered with a piece of Parafilm. The 
slides were then incubated in a humidified chamber in a 4C refrigerator overnight.  
 
The next day, the slides were rinsed 5x for 5 minutes in 1X TBS at room temperature. 
Secondary antibody was diluted in blocking solution (for Biotin-SP-conjugated 
AffiniPure Donkey anti-rabbit IgG, dilute 1:200). The secondary antibody was applied 
onto the slides and then incubated for 1 hour at room temperature in a humidified 
chamber. The slides were rinsed 5x for 5 minutes in TBS. Alexa Flour 594-Strepavidin 
1:450 was diluted in a 900µl in 50% glycerol and applied to each slide and incubated for 
30 minutes at room temperature. The slides were then rinsed 8x for 4 minutes in TBS. 
The slides were allowed to air dry at room temperature for 3 hours in the dark. 15µl of 




with a cover sip. The slides sat at room temperature for 24 hours before the coverslips 
were sealed with nail polish. Afterwards, the slides were stored in the -80C refrigerator 






 The weight of the mice that was recorded each week post tamoxifen injections 
showed that there was a decrease in weight of the Drosha KO mice around 12 weeks of 
about 3-4 grams which was expected while the control mice had no decline in weight. 
The KO mice died in a time period of 11-12 weeks. This was due to the inability of the 





Figure 1. Weight of Drosha knockout (KO) and control mice taken each week post 
tamoxifen injection over a period of 10 weeks. After each tamoxifen injection, the mice 
were placed on a scale each week for 10 weeks and the weight of each was noted. The 
control mice have a steady, increased weight over this period, whereas the KO mice 





injection. The KO mice died typically at 11-12 weeks of age due to the deterioration of 
muscles in the gastrointestinal tract.  
 
 
Gross images were taken of the mice at 4, 8, and 12 weeks post injection. These images 
showed the stages of dilation of the colon and jejunum in the Drosha KO mice. Most 
likely this cause in dilation was due to inflammation of the smooth muscle cells. Initially 
we were looking at only the colon and jejunum, but the movement of dilation was 
moving down the whole GI tract starting from the duodenum, the proximal and distal 
jejunum, the ileum, and the proximal and distal colon. Over time, the tissues from the KO 
mice became very swollen. This was seen specifically in the 12-week old mice, where the 
colon can be clearly identified by swelling and discoloration, specifically in the 




Figure 2. Gross images of the morphological changes in Drosha KO and control 




sacrificed and dissected at different time periods after injections. Over time, there is a 
noticeable difference in the gut, starting at 8 weeks for the KO compared to the control, 
and extreme dilation in the 12 week KO mouse compared to the control.  The dilated 




Figure 3. Gross images of the gastrointestinal track from the stomach to the rectum 
of both KO and control mice from 4, 8, and 12 weeks post-injection. The gross 
morphological images show the parts of the gastrointestinal tract starting from the 
stomach (the bottom of each picture), the duodenum, the proximal and distal jejunum, 
the ileum, the caecum, and finally the ascending and descending colon, ending at the 
rectum (top of each image). The images show the level of dilation post tamoxifen 
injection over a period of 4, 8, and 12 weeks. At 8 weeks post injection, the KO mouse 
started displaying signs of dilated tissue in the duodenum in which the hypertrophy 
moved distally through the proximal and distal jejunum and ended at the border of the 
ileum.  
 
The slides that were used for immunohistochemistry and H&E staining were analyzed 
under the brightfield microscope. The 4, 8, and 12 week post-injection Drosha knockout 




KO model, there were signs of hypertrophy beginning in the circular and longitudinal 
muscle layers of the jejunum. In the 12 week model, the KO displayed extreme 
hypertrophy in which the cells are seen to have increased in number and become larger. 
The hypertrophy causes an increase in size of the tissue of the jejunum, which is a result 
of the cells in the tissue enlarging and increasing in number. This is due to abnormal 
gene expression because of a lack of miRNA expression.  
 
 
 Figure 4. Images of H&E stained slides of both KO and control jejunum of Drosha 
mice at 4, 8, and 12 weeks post injection At 4 weeks, both the KO and control jejunum 
have not become distinct from one another. At this young age there have been no signs of 
irregularity in the cell composition and number. At 8 weeks, there are signs of 
hypertrophy in the KO model in which there can be seen a large increase in cell number 
compared to the control mouse jejunum. In the 12 week KO, there is a clear difference in 





In the following figures, each slide will show the magnification of the cells of the mice 
jejunum at 4, 8, and 12 weeks post tamoxifen injection. This will give a clearer image of 
the hypertrophy that has occurred in the 8 and 12 week old KO mice compared to the 





Figure 5. Images of the 4 week post-injection KO and control mice jejunum which 
magnifies the longitudinal and circular layer (200 µm in whole slide and 20µm in 
magnified slide). In the 4 week post injected KO mouse, there is no difference in the 
longitudinal muscle layers (superior striated cells) or the circular muscle layer (inferior 






Figure 6. Images of the 8 week old KO and control mice jejunum which magnifies 
the longitudinal and circular layer (200 µm in whole slide and 20µm in magnified 
slide). In the 8 week post injected KO mouse, there is hypertrophy in the longitudinal 
muscle layers (superior striated cells) and the circular muscle layer (inferior circular 
purple cells) compared to the control mouse. In both muscle layers, there is an increase in 






Figure 7. Images of the 12 week old KO and control mice jejunum which magnifies 
the longitudinal and circular layer (200 µm in whole slide and 20µm in magnified 
slide). In the 12 week post injected KO mouse, there is hypertrophy in the longitudinal 
muscle layers (superior striated cells) and the circular muscle layer (inferior circular 
purple cells) compared to the control mouse. In both muscle layers, there is the largest 






Figure 8. Differences in thickness of the circular and longitudinal layers of the 
jejunum in KO and control mice at 4, 8, and 12 weeks post-injection. Both layers of 
the KO jejunum show significant differences in thickness due to hypertrophy compared 
to the control mouse. The longitudinal layer of the KO shows an increased thickness over 
time on a scale of 0-35µm, and the largest difference in thickness, which is 15µm, is 
shown at 12 weeks. The circular layer shows an increased thickness over time in the KO 
mouse compared to the control mouse on a scale of 0-60µm. The largest difference is in 
the 12 week mouse, which is about a 25µm difference.  
 
 
This hypertrophy and inflammation in the 8 and 12 week mouse models ultimately led to 
the death of the KO mouse at around the 12 week mark, but there were specimens that 
died at 9 weeks post tamoxifen. The specimens were used in motility studies to test for 






Figure 9.  Gross images of 9 week post tamoxifen injection of mouse and mouse GI. 
KO mouse before impending death shows the compacted GI tract composed of 







Figure 10. Gross images of 9 week post tamoxifen injection of mouse and mouse GI. 
The KO mouse shows compacted food in the GI tract in the duodenum and jejunum. The 
intestines are transparent.  
 
 The hypertrophy in Figures 3 and 4 was caused by irregular gene expression due to the 
knocking out of miRNAs and the compaction of undigested food shown in Figures 9 and 
10 resulted in the gut not being able to perform muscle contractions, so that the mouse 
could not pass materials out of its digestive tract leading to lack of gastric motility and 
eventually death.  
Confocal images were taken to see the expression of MYH11, DAPI, Ki-67, SRF, and 
PDGRF α and β. The following images were taken to see the changes in cells post 




Figure 11. Confocal image of control mouse longitudinal and circular muscle layers 
of the jejunum stained with SRF and DAPI 8 weeks post injection. The green color 
shows SRF stained cells which indicates the expression of contractile and cytoskeletal 
genes. The blue color indicates DAPI stained cells, which is a marker for cellular nuclei.  
 
Figure 12. Confocal image of KO mouse longitudinal and circular muscle layers of 








color indicates DAPI in both muscle layers, which is a marker for cellular nuclei. There is 
no expression of SRF in this tissue.  
 
 
The control mouse expresses both SRF and DAPI. SRF is a master switch for the 
expression of contractile and cytoskeletal genes and is expressed in the longitudinal 
muscle layer of the control.  Unlike in the control, the KO mouse does not express SRF in 
either muscle layer. 
Figure 13. Confocal image of control and KO mouse jejunum stained with Ki67 and 
DAPI 8 weeks post injection. The blue color indicates the expression of DAPI, a marker 
for cellular nuclei. The red color indicates Ki67, which is a marker for cell proliferation 
and upregulation in hypertrophic tissues in the GI. The KO mouse clearly expresses more 
Ki67 in the circular layer of the jejunum than the control. 
 
In the image above, both DAPI and Ki67 are expressed in the control and KO jejunum of 












in the KO mouse than the control mouse. This indicates that Ki67 is being expressed 
more in the KO tissue.  
Figure 14. Confocal images of the longitudinal and circular smooth muscle layer of 8 
week post injection control mouse jejunum stained with PDGRF alpha, MYH11, 
and DAPI. The red color indicates PDGRF α, which is a tyrosine protein kinase that is a 
surface cell receptor, which either promotes or inhibits cell proliferation and survival. 
MYH11 is a marker for differentiated smooth muscle and is shown in green. The blue 









Figure 15. Confocal images of the longitudinal and circular smooth muscle layer of 8 
week post injection KO mouse jejunum stained with PDGRF alpha, MYH11, and 
DAPI. The red color indicates PDGRF α, which is a tyrosine protein kinase that is a 
surface cell receptor, which either promotes or inhibits cell proliferation and survival. 
MYH11 is a marker for differentiated smooth muscle and is shown in green. The blue 
color indicates DAPI, which is a marker for cell nuclei. There is a slight decrease in 
PDGRF α in the 8 week KO model compared to the control model. 
 
The 8 week post injection KO and control model have been stained with PDGRF α, 
MYH11, and DAPI. There is a slight decrease in PDGRF α in the 8 week KO model 
compared to the control model. A western blot analysis is needed to quantify the proteins 








Figure 16. Confocal images of the longitudinal and circular smooth muscle layer of 
12 week post injection control mouse jejunum stained with PDGRF alpha, MYH11, 
and DAPI. The red color indicates PDGRF α, which is a tyrosine protein kinase that is a 
surface cell receptor, which either promotes or inhibits cell proliferation and survival. 
MYH11 is a marker for differentiated smooth muscle and is shown in green. The blue 








Figure 17. Confocal images of the longitudinal and circular smooth muscle layer of 
12 week post injection KO mouse jejunum stained with PDGRF alpha, MYH11, and 
DAPI. The red color indicates PDGRF α, which is a tyrosine protein kinase that is a 
surface cell receptor, which either promotes or inhibits cell proliferation and survival. 
MYH11 is a marker for differentiated smooth muscle and is shown in green. The blue 
color indicates DAPI, which is a marker for cell nuclei. There is a decrease in PDGRF α 
in the 12 week KO model compared to the control model. 
 
The 12 week post injection KO and control model have been stained with PDGRF α, 
MYH11, and DAPI. No significant changes have been noted in the 12 week model, but 
there does seem to be a decrease in expression of PDGRF α. In the following images, the 






Figure 18. Confocal images of the longitudinal and circular smooth muscle layer of 8 
week post injection control mouse jejunum stained with PDGRF beta, MYH11, and 
DAPI. The red color indicates PDGRF β, which is a tyrosine protein kinase that is a 
surface cell receptor that is expressed during wound response. MYH11 is a marker for 
differentiated smooth muscle and is shown in green. The blue color indicates DAPI, 








Figure 19. Confocal images of the longitudinal and circular smooth muscle layer of 8 
week post injection KO mouse jejunum stained with PDGRF beta, MYH11, and 
DAPI. The red color indicates PDGRF β, which is a tyrosine protein kinase that is a 
surface cell receptor that is expressed during wound response. MYH11 is a marker for 
differentiated smooth muscle and is shown in green. The blue color indicates DAPI, 
which is a marker for cell nuclei. The PDGRF β is showing more expression than the 
control tissue. 
 
Compared to the PDGRF α cells, which are decreased in the 8 week post injection KO, 
the PDGRF β that is shown during wound response, is expressed reciprocally. The 








Figure 20. Confocal images of the longitudinal and circular smooth muscle layer of 
the 12 week post injection control mouse jejunum stained with PDGRF beta, 
MYH11, and DAPI. The red color indicates PDGRF β, which is a tyrosine protein 
kinase that is a surface cell receptor that is expressed during wound response. MYH11 is 
a marker for differentiated smooth muscle and is shown in green. The blue color indicates 









Figure 21. Confocal images of the longitudinal and circular smooth muscle layer of 
the 12 week post injection KO mouse jejunum stained with PDGRF beta, MYH11, 
and DAPI. The red color indicates PDGRF β, which is a tyrosine protein kinase that is a 
surface cell receptor that is expressed during wound response. MYH11 is a marker for 
differentiated smooth muscle and is shown in green. The blue color indicates DAPI, 
which is a marker for cell nuclei. In the control, PDGRF β is showing much more 
expression than in the control 12 week post injection tissue.  
 
IHC images taken under the confocal microscope indicate that PDGRF α and β cells are 
expressed reciprocally. In the 8 and 12 week models for α, PDGRF α shows a slight 
decrease in expression in the KO compared to the control, but western blot analysis is 
needed to confirm this observation. In the PDGRF β 8 and 12 week models, the control 
shows very little expression of β, but for the KO mice, PDGRF β is highly expressed 











 In this study, there was a severe phenotype change in the inducible Drosha 
knockout mice gastrointestinal tract. The Drosha KO models showed significantly thicker 
longitudinal and circular muscle layers, as well as abnormal smooth muscle cells in these 
layers. As seen in Figures 6 and 7, the hypertrophied gastrointestinal tissue is a similar 
feature of congenital MMIHS or CIPO. MMIHS causes functional intestinal obstruction 
in newborns, and it is the most severe form of obstruction and is often found fatal 
(Anneren et. al., 2005). Although the cellular mechanisms of this disease are uncertain, 
the main form of this disease causes abdominal swelling caused by abnormal smooth 
muscle cells (Park, Yan, et al., 2011). The abnormality expressed in Drosha KO SMCs 
could suggest that this mouse model can be useful in future studies of MMIHS and CIPO, 
two diseases that are dependent on the expression of miRNAs located in SMCs of the GI 
tract.  
 There was hypertrophy in both the circular and longitudinal muscle layers in the 
jejunum of the mutant mice. The jejunum expressed a grossly inflamed phenotype shown 
in Figures 2 and 3. Through analysis of H&E staining, both the jejunum and colon SM 
layers confirmed that there was, in fact, hypertrophied tissue. Also in the 12 week post 
injection model, mouse death was expected as a result of degeneration of the smooth 
muscle in which SMCs maintain proper function without the presence of miRNAs. The 
images showed only hypertrophy and inflammation and no degeneration of the smooth 
muscle, leading to an interesting phenotype. This phenotype is likely a result for 




Figures 9 and 10, there is obstruction of the bowels starting at the duodenum and jejunum 
and clearly show a complete loss of gastric motility at the terminal time point for the 
mice. There is a compaction of undigested food in these sections of the GI. Transparent 
tissue can be seen at the distal section of the GI in Figure 10, which suggests the loss of 
SMC function. Due to the obstruction and inability for food to move through the GI, the 
ability for contraction and mobility throughout the GI decreased considerably to the point 
of complete loss of muscle function, which led to the subsequent death of the Drosha KO 
model.  
 Immunohistochemistry studies suggested that there was an increase in cell 
number, as shown in Figure 13. The Ki67 protein is highly expressed in the KO model at 
8 weeks post injection, suggesting that cells have proliferated when the tissue 
hypertrophied. Since miRNAs have been knocked out of the model, the proliferation of 
cells is justified because without the presence of miRNAs, there is no suppression of 
proliferating cells. The lack of expression of SRF in Figure 12 suggests that it is not 
regulating gene expression for muscle development and function and is also not 
maintaining the contractile phenotype in the KO mouse. There is a reciprocal expression 
of PDGRF α and β cells, in which PDGRF β KO is expressed more over time than the β 
control, as well as the PDGRF α marked slides. This indicates that the hypertrophy 
shown in the GI tract at the terminal time period is similar to an actual response to injury. 
From previous studies, miRNAs affect cells in specific tissues depending on the cell 
type, location of the cells, and the point in time in which the Drosha cells are interrupted 
during development (Park, Yan et al., 2011). In the same study, the expression of smooth 




miRNAs disappear in SMCs during the activation of Cre. On account of this, the 
phenotype of the KO mice can be explained partially by the loss of SMC-specific miR-
143 and miR-145, which regulate growth and differentiation for SMCs. The development 
and survival of SMCs in the gastrointestinal tract rely on the positive and negative 
feedback by miRNAs in the smooth muscle cells themselves as well as the transcriptional 
factors that Drosha functions inside of the cell.  The SMC-specific Drosha KO mice GI 
tract had severe inflammation, SM hypertrophy, and loss of gastrointestinal motility 
leading to death after 3 months. Also, from IHC studies, Drosha KO SMCs may be de-
differentiated and become proliferative myofibroblast like cells (PDGRF αlow and βhigh 
cells). With this, Drosha (miRNAs) in SMCs is essential to maintain a contractile 
phenotype and normal motility in the GI tract.   
 
FUTURE STUDIES 
Functional experiments need to be done on the parts of the GI such as the colon and 
jejunum as well as fecal motility studies to examine how SMCs are functioning. These 
experiments are needed in order to test for the degree of motility and complete molecular 
mechanisms required for maintenance and development of contractile activity SMCs in 
the KO mouse. Also, confocal images need to be taken on the slides that underwent 
immunohistochemistry in order to see the expression of with MYH11 to investigate the 
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